Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Rectal Neoplasms × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13 Polycystic Ovary Syndrome 7 Neoplasms 3 Endometrial Neoplasms 3 Prostatic Neoplasms 2 Obesity 2 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Weight Gain 1 Vomiting 1 Venous Thromboembolism 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Smoking 1 Skin Toxicity 1 Sarcoma 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Recurrence 1

Interventions

Oxaliplatin 156 Capecitabine 141 Fluorouracil 131 Leucovorin 92 Radiotherapy 90 Irinotecan 79 Bevacizumab 58 Surgical Procedures, Operative 46 Drug Therapy 34 Cetuximab 31 Neoadjuvant Therapy 30 Radiation 28 Chemoradiotherapy 28 Folfox protocol 25 Chemotherapy, Adjuvant 20 XELOX 19 Radiotherapy, Intensity-Modulated 17 Proctectomy 15 Magnetic Resonance Spectroscopy 14 Surveys and Questionnaires 13 trifluridine tipiracil drug combination 11 Floxuridine 11 Early Intervention, Educational 11 Nivolumab 10 Consolidation Chemotherapy 10 Biopsy 10 regorafenib 9 Panitumumab 9 Mastectomy, Segmental 9 Immunohistochemistry 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04503694 2025-03-05

REGINA

Jules Bordet Institute

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡